Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Blue Oak Nutraceuticals has developed Mitokatlyst™–E, a clinically tested nutraceutical containing (-)-epicatechin. Clinical studies have shown improvements in muscle strength and endurance within 30–120 days. The product is manufactured in a US FDA-approved cGMP facility and is designed to stimulate mitochondrial biogenesis, support ATP production, protect mitochondria from damage/dysfunction, and promote healthy inflammatory responses. Over 15 preclinical and clinical studies have been conducted on the key ingredient.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Blue Oak Nutraceuticals.